Cargando…
Plasma extracellular vesicle derived protein profile predicting and monitoring immunotherapeutic outcomes of gastric cancer
Immune checkpoint inhibitor (ICI)‐based immunotherapy brought new hope for gastric cancer (GC) treatment. However, due to the lack of proper biomarkers, patient selection and outcome prediction for GC's immunotherapy remain unsatisfying. In this study, through applying an extracellular vesicle...
Autores principales: | Zhang, Cheng, Chong, Xiaoyi, Jiang, Fangli, Gao, Jing, Chen, Yang, Jia, Keren, Fan, Meng, Liu, Xuan, An, Jin, Li, Jian, Zhang, Xiaotian, Shen, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971562/ https://www.ncbi.nlm.nih.gov/pubmed/35362262 http://dx.doi.org/10.1002/jev2.12209 |
Ejemplares similares
-
Extracellular Vesicle-Derived Protein File from Peripheral Blood Predicts Immune-Related Adverse Events in Gastric Cancer Patients Receiving Immunotherapy
por: Jiang, Fangli, et al.
Publicado: (2022) -
Immunotherapeutic Potential of Extracellular Vesicles
por: Zhang, Bin, et al.
Publicado: (2014) -
ANO1‐Mediated Inhibition of Cancer Ferroptosis Confers Immunotherapeutic Resistance through Recruiting Cancer‐Associated Fibroblasts
por: Jiang, Fangli, et al.
Publicado: (2023) -
Abscopal Effect, Extracellular Vesicles and Their Immunotherapeutic Potential in Cancer Treatment
por: Salazar, Aleli, et al.
Publicado: (2023) -
Multiplex immunohistochemistry defines the tumor immune microenvironment and immunotherapeutic outcome in CLDN18.2-positive gastric cancer
por: Jia, Keren, et al.
Publicado: (2022)